| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/15/2004 | CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications |
| 12/15/2004 | CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/15/2004 | CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 12/15/2004 | CN1179741C Compound Chinese medicine for treating cerebrovascular disease |
| 12/15/2004 | CN1179735C Litholytic medicine for treating hepatolith and preparation process thereof |
| 12/15/2004 | CN1179722C Parkinson's disease treating preparing contg. astrocyte function improver as active component |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
| 12/14/2004 | US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/14/2004 | US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 12/14/2004 | US6831094 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
| 12/14/2004 | US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 12/14/2004 | US6831089 1,4-di-substituted piperidines, some of which have M2 selectivity even higher than that of 3-alpha-chloroimperialine for treating cognitive disorders such as Alzheimer's disease |
| 12/14/2004 | US6831087 2-(Pyrid-2- or 4-yl)-1,2,3,4-tetrahydroisoquinoline and derivatives; a good affinity to the NMDA receptor (N-methyl-D-asparate); acute/cronic neurodegenerative diseases; bacterial/viral infections; antidepressants; analgesics |
| 12/14/2004 | US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof |
| 12/14/2004 | US6831080 Cinnamide derivatives as KCNQ potassium channel modulators |
| 12/14/2004 | US6831078 3-aryl substituted having halo or alkylhalo groups; anxiety, epilepsy; presurgery muscle relaxant |
| 12/14/2004 | US6831075 Heterocyclic substituted pyrazolones |
| 12/14/2004 | US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 12/14/2004 | US6831066 Amyloid precursor proteins with improved bioavailability; for treament of Alzheimer's disease |
| 12/14/2004 | US6831065 Anti-inflammatory compounds and uses thereof |
| 12/14/2004 | US6830894 Compounds and methods for modulating claudin-mediated functions |
| 12/14/2004 | US6830755 Method for relaxing human beings using personal care compositions |
| 12/14/2004 | US6830750 Reduction of oxidative stress factors with Lactobacillus plantarum |
| 12/14/2004 | CA2235038C Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 12/14/2004 | CA2136075C Heterocyclic ether compounds that enhance cognitive function |
| 12/13/2004 | CA2470263A1 New benzothiazine and benzothidiazine derivatives, their process of production and pharmaceutical compositions contained therein |
| 12/13/2004 | CA2470065A1 New derivatives of benzothiazine and benzothidiazine, preparation process thereof, and the pharmaceutical compounds containing them |
| 12/13/2004 | CA2468651A1 Detection of neurodegenerative diseases |
| 12/09/2004 | WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 12/09/2004 | WO2004106935A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 12/09/2004 | WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 12/09/2004 | WO2004106932A1 Method for selecting allosteric regulators of class iii g protein-coupled receptors |
| 12/09/2004 | WO2004106348A1 Aminomethyl-substituted fluorothiazolobenzimidazole derivative |
| 12/09/2004 | WO2004106346A1 Indole derivatives with an improved antipsychotic activity |
| 12/09/2004 | WO2004106322A2 Polymorphs of aripiprazole |
| 12/09/2004 | WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use |
| 12/09/2004 | WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof |
| 12/09/2004 | WO2004106306A1 Novel ureido - and amido-pyrazolone derivatives |
| 12/09/2004 | WO2004106298A1 Indole derivatives with an improved antipsychotic activity |
| 12/09/2004 | WO2004106290A1 Amino alcohol derivatives, phamaceutical compositions containing the same, and use of both |
| 12/09/2004 | WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these |
| 12/09/2004 | WO2004106281A1 Crystalline gabapentin |
| 12/09/2004 | WO2004106275A2 Compounds useful in the therapy of alzheimer’s disease and formulations containing them |
| 12/09/2004 | WO2004105789A1 Grf analog compositions and their use |
| 12/09/2004 | WO2004105766A2 Use of lornoxicam or lornoxicam analogue compounds |
| 12/09/2004 | WO2004105756A2 Combination comprising (a) a neuroprotecting agent and (b) an agent binding to gadph and pharmaceutical use thereof |
| 12/09/2004 | WO2004105755A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 12/09/2004 | WO2004105753A1 Antidepressant or food or beverage for antidepression |
| 12/09/2004 | WO2004105750A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers |
| 12/09/2004 | WO2004105749A1 Composition having autonomic nerve modulating activity and method of use thereof |
| 12/09/2004 | WO2004105746A1 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
| 12/09/2004 | WO2004105744A1 Use of iron for treating attention deficit hyperactivity disorder in children |
| 12/09/2004 | WO2004105743A1 Deramciclane-fumarate tablets |
| 12/09/2004 | WO2004105514A1 Wort and malt extract, process for producing the same and nonalcoholic drink or food containing the same |
| 12/09/2004 | WO2004096761A8 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 12/09/2004 | WO2004092173A3 A2a adenosine receptor antagonists |
| 12/09/2004 | WO2004089349A3 Use of an alpha2-adrenoceptor antagonist for the treatment of epilepsy |
| 12/09/2004 | WO2004083851A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
| 12/09/2004 | WO2004071413A3 Method and composition for potentiating an opiate analgesic |
| 12/09/2004 | WO2004060262A3 Modulators of notch signalling for use in immunotherpapy |
| 12/09/2004 | WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/09/2004 | WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 12/09/2004 | WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators |
| 12/09/2004 | WO2003080582A3 Fredericamycin derivatives |
| 12/09/2004 | WO2003057835A3 Pak5-related compositions and methods |
| 12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 12/09/2004 | US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders |
| 12/09/2004 | US20040250304 Novel collagen-like protein clac, precussor thereof and genes encoding the same |
| 12/09/2004 | US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 12/09/2004 | US20040249161 Biphenyl-derivatives as p38-kinase inhibitors |
| 12/09/2004 | US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders |
| 12/09/2004 | US20040249148 Hydrolase enzyme inhibitors comprising nitrogen compounds such as 2-(3,4-Dimethoxyphenyl)-7-(1-ethylpropyl)-5-methyl-4-(3,4,5-trimethoxyphenoxy)-imidazo[5,1-f][1,2,4]triazine, used for prophylaxis of neurodegenerative disorders |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249125 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248978 Synergistic pain treatment, side effect reduction; a mixture of pregabalin or tiagabine and 2-[4-(2-fluorobenzyloxy) benzylamino] propanamide |
| 12/09/2004 | US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 12/09/2004 | US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release |
| 12/09/2004 | US20040248946 Beverage treated with nicotine |
| 12/09/2004 | US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
| 12/09/2004 | US20040248933 tertiary carbocyclic amines such as 4,7-diphenyl-2-methyl-1,2,3,4-tetrahydroisoquinoline, having preferential binding norepinephrine transporter protein (NET) over the other neurotransmitter transporters; side effect reduction |
| 12/09/2004 | US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 12/09/2004 | US20040248931 Poly(ADP-ribose)polymerase inhibitors; cerebral infarction; such as 3-[2-(3-hydroxypyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one; synthesis |
| 12/09/2004 | US20040248925 Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
| 12/09/2004 | US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/09/2004 | US20040248919 Insulin sensitizers which do not increase triglyceride levels or suppress thyroid hormone axis; such as 7-[3,5-di-tert-butyl-2-(2,2-difluoroethoxy)-phenyl]-4-fluoro-3-methyl-octa-2,4,6-trienoic acid; synthesis; retinoid X receptor (rxr) |
| 12/09/2004 | US20040248913 (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators |
| 12/09/2004 | US20040248909 Adenosine a1 receptor antagonist for treating hypoxia-induced learning memory impairment |
| 12/09/2004 | US20040248904 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 12/09/2004 | US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 12/09/2004 | US20040248893 Isoxazolopyridinones |
| 12/09/2004 | US20040248889 Analgesics; synthesis |
| 12/09/2004 | US20040248888 Metabotropic glutamate (mGluR5) receptor mediated disorders; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain; containing pyridin-4-ylethynyl functionality |
| 12/09/2004 | US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide |
| 12/09/2004 | US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 12/09/2004 | US20040248883 Novel heteroaryl derivatives, their preparation and use |